Nanovibronix Stock Debt To Equity
| NAOV Stock | USD 0.76 0.01 1.33% |
NanoVibronix fundamentals help investors to digest information that contributes to NanoVibronix's financial success or failures. It also enables traders to predict the movement of NanoVibronix Stock. The fundamental analysis module provides a way to measure NanoVibronix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NanoVibronix stock.
NanoVibronix |
NanoVibronix Company Debt To Equity Analysis
NanoVibronix's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current NanoVibronix Debt To Equity | 0.01 % |
Most of NanoVibronix's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NanoVibronix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
According to the company disclosure, NanoVibronix has a Debt To Equity of 0.008%. This is 99.99% lower than that of the Health Care Equipment & Supplies sector and 99.98% lower than that of the Health Care industry. The debt to equity for all United States stocks is 99.98% higher than that of the company.
NanoVibronix Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NanoVibronix's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of NanoVibronix could also be used in its relative valuation, which is a method of valuing NanoVibronix by comparing valuation metrics of similar companies.NanoVibronix is currently under evaluation in debt to equity category among related companies.
NanoVibronix Fundamentals
| Return On Equity | -1.03 | ||||
| Return On Asset | -0.31 | ||||
| Profit Margin | (1.63) % | ||||
| Operating Margin | (0.29) % | ||||
| Current Valuation | (1.17 M) | ||||
| Shares Outstanding | 2.78 M | ||||
| Shares Owned By Insiders | 0.42 % | ||||
| Shares Owned By Institutions | 12.00 % | ||||
| Number Of Shares Shorted | 2.51 K | ||||
| Price To Earning | (5.34) X | ||||
| Price To Book | 0.53 X | ||||
| Price To Sales | 0.93 X | ||||
| Revenue | 2.28 M | ||||
| Gross Profit | 167 K | ||||
| EBITDA | (3.44 M) | ||||
| Net Income | (3.71 M) | ||||
| Cash And Equivalents | 3.94 M | ||||
| Cash Per Share | 0.14 X | ||||
| Total Debt | 5 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 3.07 X | ||||
| Book Value Per Share | 1.95 X | ||||
| Cash Flow From Operations | (3.6 M) | ||||
| Short Ratio | 0.10 X | ||||
| Earnings Per Share | (2.12) X | ||||
| Target Price | 10.5 | ||||
| Number Of Employees | 10 | ||||
| Beta | 1.27 | ||||
| Market Capitalization | 2.11 M | ||||
| Total Asset | 6.67 M | ||||
| Retained Earnings | (66.1 M) | ||||
| Working Capital | 4.03 M | ||||
| Current Asset | 1.78 M | ||||
| Current Liabilities | 297 K | ||||
| Net Asset | 6.67 M |
About NanoVibronix Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NanoVibronix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NanoVibronix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NanoVibronix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out NanoVibronix Piotroski F Score and NanoVibronix Altman Z Score analysis. For more information on how to buy NanoVibronix Stock please use our How to Invest in NanoVibronix guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for NanoVibronix Stock analysis
When running NanoVibronix's price analysis, check to measure NanoVibronix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoVibronix is operating at the current time. Most of NanoVibronix's value examination focuses on studying past and present price action to predict the probability of NanoVibronix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoVibronix's price. Additionally, you may evaluate how the addition of NanoVibronix to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is NanoVibronix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NanoVibronix. If investors know NanoVibronix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NanoVibronix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NanoVibronix is measured differently than its book value, which is the value of NanoVibronix that is recorded on the company's balance sheet. Investors also form their own opinion of NanoVibronix's value that differs from its market value or its book value, called intrinsic value, which is NanoVibronix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NanoVibronix's market value can be influenced by many factors that don't directly affect NanoVibronix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NanoVibronix's value and its price as these two are different measures arrived at by different means. Investors typically determine if NanoVibronix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NanoVibronix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.